The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
Authors
Keywords
-
Journal
DIABETES CARE
Volume 44, Issue 12, Pages 2729-2737
Publisher
American Diabetes Association
Online
2021-09-30
DOI
10.2337/dc21-1304
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relationship Between Core Continuous Glucose Monitoring Metrics, including Time in Range, and Cardiovascular Autonomic Neuropathy in Outpatients with Type 2 Diabetes
- (2021) Min Young Kim et al. Diabetes Technology & Therapeutics
- An Evaluation of Two Capillary Sample Collection Kits for Laboratory Measurement of HbA1c
- (2021) Roy W. Beck et al. Diabetes Technology & Therapeutics
- Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin
- (2021) Thomas Martens et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes
- (2020) Qingyu Guo et al. Journal of Diabetes Research
- Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease
- (2020) Laura Mayeda et al. BMJ Open Diabetes Research & Care
- Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes
- (2020) Jee Hee Yoo et al. Diabetes Technology & Therapeutics
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes
- (2020) Richard E. Pratley et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study
- (2020) Jingyi Lu et al. DIABETES CARE
- Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump–Treated Type 1 Diabetes
- (2020) Ajenthen G. Ranjan et al. DIABETES CARE
- Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data
- (2020) Anne Peters et al. DIABETES OBESITY & METABOLISM
- Time in range is associated with carotid intima-media thickness in type 2 diabetes
- (2019) Jingyi Lu et al. Diabetes Technology & Therapeutics
- A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)
- (2018) Arndís F. Ólafsdóttir et al. Diabetes Technology & Therapeutics
- Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
- (2018) Jingyi Lu et al. DIABETES CARE
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
- (2018) Roy W. Beck et al. DIABETES CARE
- Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections
- (2017) Marcus Lind et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections
- (2017) Roy W. Beck et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
- (2012) T. Battelino et al. DIABETOLOGIA
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started